Norepinephrine Bitartrate Injection, Solution, Concentrate
NDC Package 83854-017-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Norepinephrine Bitartrate injection is  is indicated to raise blood pressure in adult patients with severe, acute hypotension. This formulation utilizes a injection, solution, concentrate delivery system. Marketed by Anthea Pharma Private Limited, this product is identified by NDC 83854-017 and is authorized under FDA application ANDA219924.

Identification & Billing

NDC Package Code
83854-017-10
Package Description
10 VIAL in 1 CARTON / 4 mL in 1 VIAL (83854-017-01)
Product Code
83854-017
11-Digit Billing Format
83854001710
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Norepinephrine Bitartrate
Non-Proprietary Name
Norepinephrine Bitartrate
Substance Name
Norepinephrine Bitartrate
Dosage Form
Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
NOREPINEPHRINE BITARTRATE 1 mg/mL
Pharmacologic Class
Usage Information
Norepinephrine Bitartrate Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension.

Regulatory & Marketing

Labeler Name
Anthea Pharma Private Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA219924
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-25-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83854-017-10 identifies a specific commercial package of 10 vial in 1 carton / 4 ml in 1 vial (83854-017-01) of Norepinephrine Bitartrate, a human prescription drug labeled by Anthea Pharma Private Limited. This injection, solution, concentrate is formulated for intravenous use and contains norepinephrine bitartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anthea Pharma Private Limited on November 25, 2025. The current certification is valid through December 31, 2026.

How is this Anthea Pharma Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83854001710. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83854-017-10
11-Digit CMS (5-4-2)
83854-0017-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.